R E Buckingham - JoVE Visualize

Showing results (31-40 of 40) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 40 results.

Canadian Journal of Physiology and Pharmacology|December 1, 1994

Potential defect in the vascular control of nonshivering thermogenesis in the obese Zucker rat hind limbT P Eldershaw, S Rattigan, K A Dora, et al.

Diabetes, Obesity & Metabolism|February 14, 2008

Energy restriction enhances therapeutic efficacy of the PPARgamma agonist, rosiglitazone, through regulation of visceral fat gene expressionG B T Moore, L C Pickavance, C P Briscoe, et al.

Diabetes, Obesity & Metabolism|June 11, 2003

Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty ratsP D Hockings, K K Changani, N Saeed, et al.

Journal of Medicinal Chemistry|November 1, 1986

Synthesis and antihypertensive activity of 4-(cyclic amido)-2H-1-benzopyransV A Ashwood, R E Buckingham, F Cassidy, et al.

Diabetes|October 27, 1999

Hypothalamic orexin expression: modulation by blood glucose and feedingX J Cai, P S Widdowson, J Harrold, et al.

Diabetes|August 14, 1998

Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty ratsR E Buckingham, K A Al-Barazanji, C D Toseland, et al.

Peptides|March 4, 2000

Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cordD J Cutler, R Morris, V Sheridhar, et al.

Obesity Research|December 31, 1997

Effects of intracerebroventricular infusion of leptin in obese Zucker ratsK A al-Barazanji, R E Buckingham, J R Arch, et al.

Circulation|November 21, 2001

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazoneT L Yue Tl, J Chen, W Bao, et al.

Cell|March 10, 1998

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behaviorT Sakurai, A Amemiya, M Ishii, et al.

Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 40 results.

Canadian Journal of Physiology and Pharmacology|December 1, 1994

Potential defect in the vascular control of nonshivering thermogenesis in the obese Zucker rat hind limbT P Eldershaw, S Rattigan, K A Dora, et al.

Diabetes, Obesity & Metabolism|February 14, 2008

Energy restriction enhances therapeutic efficacy of the PPARgamma agonist, rosiglitazone, through regulation of visceral fat gene expressionG B T Moore, L C Pickavance, C P Briscoe, et al.

Diabetes, Obesity & Metabolism|June 11, 2003

Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty ratsP D Hockings, K K Changani, N Saeed, et al.

Journal of Medicinal Chemistry|November 1, 1986

Synthesis and antihypertensive activity of 4-(cyclic amido)-2H-1-benzopyransV A Ashwood, R E Buckingham, F Cassidy, et al.

Diabetes|October 27, 1999

Hypothalamic orexin expression: modulation by blood glucose and feedingX J Cai, P S Widdowson, J Harrold, et al.

Diabetes|August 14, 1998

Peptides|March 4, 2000

Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cordD J Cutler, R Morris, V Sheridhar, et al.

Obesity Research|December 31, 1997

Effects of intracerebroventricular infusion of leptin in obese Zucker ratsK A al-Barazanji, R E Buckingham, J R Arch, et al.

Circulation|November 21, 2001

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazoneT L Yue Tl, J Chen, W Bao, et al.

Cell|March 10, 1998

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behaviorT Sakurai, A Amemiya, M Ishii, et al.

Pageof 4